Sarepta Therapeutics has been waiting, hoping and lobbying for approval of its Duchenne muscular dystophy drug eteplirsen for years. And now--despite intra-…

Mylan saw EpiPen pricing trouble coming months ago. So the company stepped up lobbying for EpiPen's move onto an official list of preventive meds that…

The FDA has banned all of the products made by an Indian drugmaker as it investigates an outbreak of dozens of hospital infections. 

Pfizer’s stop-smoking drug Chantix may be one step closer to escaping the FDA’s black box. An agency advisory panel narrowly voted in favor of removing the FDA…

Congress is starting to get some answers on EpiPen pricing. And though, so far, Mylan’s not offering much beyond what’s readily available via Google search,…

Generic drug prices in Medicare Part D decreased significantly in recent years. So why the worry about price hikes? "Extraordinary" increases on…

FDA scientists are looking askance at Pfizer’s latest attempt to lift a black-box warning from its stop-smoking drug Chantix.

Pfizer CEO Ian Read called Hillary Clinton's plan to curb drug prices "very negative for innovation."